Biotechnology Stocks I Performance Guide: TG Therapeutics, Inc. (TGTX)
TGTX has no dividends.
Table and Chart of TGTX Performance
See what a $1,000 investment in TGTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TGTX Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $6.53 |
| End Date | May-08-2024 |
| End Price | $17.12 |
| # Prices | 121 |
| Min Date | Jan-31-2019 |
| Min Price | $4.10 |
| Max Date | Dec-31-2020 |
| Max Price | $52.02 |
| Total Return | 162.17% |
| Annualized Return | 10.03% |
| Current Value of $1,000 Purchase | $2,622 |
| Number Returns | 7,260 |
| Average Return | 68.47% |
| Number Profitable Returns | 4,226 |
| Percent Profitable Returns | 58.21% |
| Number Unprofitable Returns | 3,034 |
| Percent Unprofitable Returns | 41.79% |
| Profitable to Unprofitable Returns Ratio | 1.39 |
| TGTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,655,049,000 |
| Beta | 2.317 | Price to Sales | 9.36 |
| Earnings per Share | $0.3000 |
| PE Ratio | 57.27 |
| PE to Growth Ratio | 0 |
| Price to Book | 13.62 |
| PRICE DATA | |
| 52 Week High | $34.8 |
| 52 Week Low | $6.46 |
| Analyst Target Price | $32.29 |
| 50-Day Moving Average | $15.35 |
| 200-Day Moving Average | $13.28 |
| FINANCIAL DATA | |
| Revenue per Share | $2.017 |
| Revenue | $289,333,000 |
| Profit Margin | 14.2% |
| Return on Equity | 11.6% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TGTX Compare Returns with S&P 500
TGTX Trendline Chart
TGTX Moving Average Chart
TGTX Stock Return Map - See Patterns of Gains and Losses
TGTX Stock Returns/Purchase Dates